1 – 10 of 93
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
EMAS position statement: The ten point guide to the integral management of menopausal health.
(
- Contribution to journal › Article
- 2014
-
Mark
Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
(
- Contribution to journal › Article
-
Mark
To pick, choose, or single out.
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Low androstenedione/sex hormone binding globulin ratio increases fracture risk in postmenopausal women. The Women's Health in the Lund Area study.
(
- Contribution to journal › Article
- 2011
-
Mark
Serum estradiol does not differentiate stress, mixed and urge incontinent women around menopause. A report from the Women's Health in the Lund Area (WHILA) study.
(
- Contribution to journal › Article
-
Mark
Hormone therapy and coronary heart disease risk by vasomotor menopausal symptoms.
(
- Contribution to journal › Article
-
Mark
Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease.
(
- Contribution to journal › Article
- 2010
-
Mark
A prospective observational study of the effects of treatment with extended-release tolterodine on health-related quality of life of patients suffering overactive bladder syndrome in Sweden
(
- Contribution to journal › Article
-
Mark
Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.
(
- Contribution to journal › Article
-
Mark
Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women.
(
- Contribution to journal › Article